Skip to main content
Top
Published in: AIDS Research and Therapy 1/2019

Open Access 01-12-2019 | Human Immunodeficiency Virus | Research

Correlates and determinants of Early Infant Diagnosis outcomes in North-Central Nigeria

Authors: Patrick Dakum, Monday Tola, Nta Iboro, Chukwuemeka A. Okolo, Olachi Anuforom, Christopher Chime, Sam Peters, Jibreel Jumare, Obinna Ogbanufe, Aliyu Ahmad, Nicaise Ndembi

Published in: AIDS Research and Therapy | Issue 1/2019

Login to get access

Abstract

Background

A negative status following confirmatory Early Infant Diagnosis (EID) is the desired pediatric outcome of prevention of Mother to Child Transmission (PMTCT) programs. EID impacts epidemic control by confirming non-infected HIV-exposed infants (HEIs) and prompting timely initiation of ART in HIV-infected babies which improves treatment outcomes.

Objectives

We explored factors associated with EID outcomes among HEI in North-Central Nigeria.

Method

This is a cross-sectional study using EID data of PMTCT-enrollees matched with results of HEI’s dried blood samples (DBS), processed for DNA-PCR from January 2015 through July 2017. Statistical analyses were done using SPSS version 20.0 to generate frequencies and examine associations, including binomial logistic regression with p < 0.05 being statistically significant.

Results

Of 14,448 HEI in this analysis, 51.8% were female and 95% (n = 12,801) were breastfed. The median age of the infants at sample collection was 8 weeks (IQR 6–20), compared to HEI tested after 20 weeks of age, those tested earlier had significantly greater odds of a negative HIV result (≤ 6 weeks: OR = 3.8; 6–8 weeks: OR = 2.1; 8–20 weeks: OR = 1.5) with evidence of a significant linear trend (p < 0.001). Similarly, HEI whose mothers received combination antiretroviral therapy (cART) before (OR = 11.8) or during the index pregnancy (OR = 8.4) had significantly higher odds as compared to those whose mothers did not receive cART. In addition, HEI not breastfed had greater odds of negative HIV result as compared to those breastfed (OR = 1.9).

Conclusions

cART prior to and during pregnancy, earlier age of HEI at EID testing and alternative feeding other than breastfeeding were associated with an increased likelihood of being HIV-negative on EID. Therefore, strategies to scale-up PMTCT services are needed to mitigate the burden of HIV among children.
Literature
1.
go back to reference Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W, Women and Infants’ Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484–94.CrossRef Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W, Women and Infants’ Transmission Study Group. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484–94.CrossRef
2.
go back to reference FMOH. National Guidelines for HIV Prevention Treatment and Care, Abuja. 2016. FMOH. National Guidelines for HIV Prevention Treatment and Care, Abuja. 2016.
4.
go back to reference Sam-Agudu NA, Ramadhani HO, Isah C, Erekaha S, Fan-Osuala C, Anaba U, Adejuyigbe EA, Charurat M. The impact of structured mentor mother programs on presentation for early infant diagnosis testing in rural north-central Nigeria: a prospective paired cohort study. J Acquir Immune Defic Syndr. 2017;75:S182–S189189.CrossRef Sam-Agudu NA, Ramadhani HO, Isah C, Erekaha S, Fan-Osuala C, Anaba U, Adejuyigbe EA, Charurat M. The impact of structured mentor mother programs on presentation for early infant diagnosis testing in rural north-central Nigeria: a prospective paired cohort study. J Acquir Immune Defic Syndr. 2017;75:S182–S189189.CrossRef
7.
go back to reference Sherman GG, Cooper PA, Coovadia AH, Puren AJ, Jones SA, Mokhachane M, Bolton KD. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005;24:993–7.CrossRef Sherman GG, Cooper PA, Coovadia AH, Puren AJ, Jones SA, Mokhachane M, Bolton KD. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005;24:993–7.CrossRef
8.
go back to reference WHO. ANNEX 1: summary of findings and quality of evidence evaluation for the use of virological testing. In: WHO Recomm. diagnosis HIV infect. infants child. Geneva: World Health Organization; 2010. WHO. ANNEX 1: summary of findings and quality of evidence evaluation for the use of virological testing. In: WHO Recomm. diagnosis HIV infect. infants child. Geneva: World Health Organization; 2010.
10.
go back to reference Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, Josipovic D, Liberty A, Lazarus E, Innes S, van Rensburg AJ, Pelser W, Truter H, Madhi SA, Handelsman E, Jean-Philippe P, McIntyre JA, Gibb DM, Babiker AG. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2016;382:1555–633. https://doi.org/10.1016/S0140-6736(13)61409-9.CrossRef Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, Josipovic D, Liberty A, Lazarus E, Innes S, van Rensburg AJ, Pelser W, Truter H, Madhi SA, Handelsman E, Jean-Philippe P, McIntyre JA, Gibb DM, Babiker AG. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2016;382:1555–633. https://​doi.​org/​10.​1016/​S0140-6736(13)61409-9.CrossRef
12.
go back to reference WHO. Antiretroviral therapy for HIV infection in infants and children: towards universal access: recommendations for a public health approach: 2010 Revision. Geneva: World Health Organization; 2010. WHO. Antiretroviral therapy for HIV infection in infants and children: towards universal access: recommendations for a public health approach: 2010 Revision. Geneva: World Health Organization; 2010.
13.
go back to reference Ubesie AC. Pediatric HIV/AIDS in sub-Saharan Africa: emerging issues and way forward. Afr Health Sci. 2012;12:297–304.PubMedPubMedCentral Ubesie AC. Pediatric HIV/AIDS in sub-Saharan Africa: emerging issues and way forward. Afr Health Sci. 2012;12:297–304.PubMedPubMedCentral
15.
go back to reference World Health Organization. Scaling up priority HIV/AIDS interventions in the health sector: Progress Report. Geneva: World Health Organization; 2010. World Health Organization. Scaling up priority HIV/AIDS interventions in the health sector: Progress Report. Geneva: World Health Organization; 2010.
16.
go back to reference Pharr JR, Obiefune MC, Ezeanolue CO, Osuji A, Ogidi AG, Gbadamosi S, Patel D, Iwelunmor J, Yang W, Ogedegbe G, Ehiri JE, Sam-Agudu NA, Ezeanolue EE. Linkage to care, early infant diagnosis, and perinatal transmission among infants born to HIV-infected Nigerian mothers: evidence from the healthy beginning initiative. J Acquir Immune Defic Syndr. 2016;72(Suppl 2):S154–S160160. https://doi.org/10.1097/QAI.0000000000001051.CrossRefPubMedPubMedCentral Pharr JR, Obiefune MC, Ezeanolue CO, Osuji A, Ogidi AG, Gbadamosi S, Patel D, Iwelunmor J, Yang W, Ogedegbe G, Ehiri JE, Sam-Agudu NA, Ezeanolue EE. Linkage to care, early infant diagnosis, and perinatal transmission among infants born to HIV-infected Nigerian mothers: evidence from the healthy beginning initiative. J Acquir Immune Defic Syndr. 2016;72(Suppl 2):S154–S160160. https://​doi.​org/​10.​1097/​QAI.​0000000000001051​.CrossRefPubMedPubMedCentral
19.
go back to reference UNAIDS. UNAIDS briefing book. Geneva; 2016. UNAIDS. UNAIDS briefing book. Geneva; 2016.
20.
go back to reference NACA, UNAIDS. Global AIDS Response Progress Report: Nigeria, Abuja. 2014. NACA, UNAIDS. Global AIDS Response Progress Report: Nigeria, Abuja. 2014.
21.
go back to reference Mei JV, Alexander JR, Adam BW, Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr. 1636S;131:1631S–6S.CrossRef Mei JV, Alexander JR, Adam BW, Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr. 1636S;131:1631S–6S.CrossRef
27.
go back to reference Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, Josipovic D, Liberty A, Lazarus E, Innes S, van Rensburg AJ, Pelser W, Truter H, Madhi SA, Handelsman E, Jean-Philippe P, McIntyre JA, Gibb DM, Babiker AG, CHER study team. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382:1555–633. https://doi.org/10.1016/S0140-6736(13)61409-9.CrossRefPubMedPubMedCentral Cotton MF, Violari A, Otwombe K, Panchia R, Dobbels E, Rabie H, Josipovic D, Liberty A, Lazarus E, Innes S, van Rensburg AJ, Pelser W, Truter H, Madhi SA, Handelsman E, Jean-Philippe P, McIntyre JA, Gibb DM, Babiker AG, CHER study team. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013;382:1555–633. https://​doi.​org/​10.​1016/​S0140-6736(13)61409-9.CrossRefPubMedPubMedCentral
29.
go back to reference Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the role of breastfeeding on the prevention of infant mortality. Lancet. 2000; 355:451–5. https://www.ncbi.nlm.nih.gov/pubmed/10841125. Accessed 6 Nov 2017). Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the role of breastfeeding on the prevention of infant mortality. Lancet. 2000; 355:451–5. https://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​10841125. Accessed 6 Nov 2017).
32.
go back to reference 2016 WHO. Updates on HIV and infant feeding guideline. 2016; 68. 2016 WHO. Updates on HIV and infant feeding guideline. 2016; 68.
33.
go back to reference Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB, HPTN 046 Protocol Team. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046). J Acquir Immune Defic Syndr. 2014;65:366–74. https://doi.org/10.1097/QAI.0000000000000052.CrossRefPubMedPubMedCentral Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB, HPTN 046 Protocol Team. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046). J Acquir Immune Defic Syndr. 2014;65:366–74. https://​doi.​org/​10.​1097/​QAI.​0000000000000052​.CrossRefPubMedPubMedCentral
34.
go back to reference UNAIDS. Global plan: Country Fact Sheet_Nigeria. Geneva; 2016. UNAIDS. Global plan: Country Fact Sheet_Nigeria. Geneva; 2016.
35.
go back to reference Datta P, Embree JE, Kreiss JK, Ndinya-Achola JO, Braddick M, Temmerman M, Nagelkerke NJ, Maitha G, Holmes KK, Piot P. Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis. 1994;170:1134–40.CrossRef Datta P, Embree JE, Kreiss JK, Ndinya-Achola JO, Braddick M, Temmerman M, Nagelkerke NJ, Maitha G, Holmes KK, Piot P. Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study. J Infect Dis. 1994;170:1134–40.CrossRef
36.
go back to reference NACA. Global AIDS Response Country Progress Report: Nigeria, Abuja. 2015. NACA. Global AIDS Response Country Progress Report: Nigeria, Abuja. 2015.
37.
go back to reference UNAIDS. Nigeria: HIV and AIDS estimates. Geneva; 2013. UNAIDS. Nigeria: HIV and AIDS estimates. Geneva; 2013.
38.
go back to reference WHO. Nigeria aligns national protocol to WHO ‘Treat All’ guidelines on HIV/AIDS prevention and treatment, Abuja. 2016. WHO. Nigeria aligns national protocol to WHO ‘Treat All’ guidelines on HIV/AIDS prevention and treatment, Abuja. 2016.
Metadata
Title
Correlates and determinants of Early Infant Diagnosis outcomes in North-Central Nigeria
Authors
Patrick Dakum
Monday Tola
Nta Iboro
Chukwuemeka A. Okolo
Olachi Anuforom
Christopher Chime
Sam Peters
Jibreel Jumare
Obinna Ogbanufe
Aliyu Ahmad
Nicaise Ndembi
Publication date
01-12-2019
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2019
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-019-0245-z

Other articles of this Issue 1/2019

AIDS Research and Therapy 1/2019 Go to the issue